Literature DB >> 6020232

Partial and "complete" adrenergic blockade in posthemorrhagic shock.

D F Halmagyi, D J Gillett, M H Irving.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6020232     DOI: 10.1152/jappl.1967.22.3.487

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


× No keyword cloud information.
  9 in total

Review 1.  Current studies in surgical shock.

Authors:  M Irving
Journal:  Proc R Soc Med       Date:  1972-12

2.  Effect of oral high frequency ventilation by jet or oscillator on minute ventilation in normal subjects.

Authors:  R J George; R J Winter; M A Johnson; I P Slee; D M Geddes
Journal:  Thorax       Date:  1985-10       Impact factor: 9.139

3.  Sustained complete autonomic blockade.

Authors:  D F Halmagyi; I R Neering; D Varga; J Pullin
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

4.  Sympatho-adrenal hyperactivity--the key to irreversible shock?

Authors:  M H Irving
Journal:  Postgrad Med J       Date:  1969-08       Impact factor: 2.401

5.  The sympatho-adrenal factor in haemorrhagic shock.

Authors:  M H Irving
Journal:  Ann R Coll Surg Engl       Date:  1968-06       Impact factor: 1.891

6.  Combined adrenergic blockade in experimental hemorrhagic hypotension.

Authors:  G Zierott; E Pappova; P Lundsgaard-Hansen
Journal:  Pflugers Arch       Date:  1969-06-24       Impact factor: 3.657

7.  Course of posthemorrhagic hypotension after celiac ganglionectomy with and without adrenal denervation.

Authors:  D F Halmagyi; M H Irving; D J Gillett
Journal:  Ann Surg       Date:  1967-08       Impact factor: 12.969

8.  Acid-base balance in acute gastrointestinal bleeding.

Authors:  T C Northfield; B J Kirby; A E Tattersfield
Journal:  Br Med J       Date:  1971-05-01

9.  Erythrocyte G protein as a novel target for malarial chemotherapy.

Authors:  Sean C Murphy; Travis Harrison; Heidi E Hamm; Jon W Lomasney; Narla Mohandas; Kasturi Haldar
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.